X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AJANTA PHARMA UNICHEM LAB/
AJANTA PHARMA
 
P/E (TTM) x -29.9 18.9 - View Chart
P/BV x 0.6 4.4 14.8% View Chart
Dividend Yield % 2.6 0.0 -  

Financials

 UNICHEM LAB   AJANTA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
AJANTA PHARMA
Mar-18
UNICHEM LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3821,818 21.0%   
Low Rs2341,106 21.2%   
Sales per share (Unadj.) Rs116.3239.5 48.6%  
Earnings per share (Unadj.) Rs-18.952.8 -35.8%  
Cash flow per share (Unadj.) Rs-11.759.5 -19.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.0230.0 165.7%  
Shares outstanding (eoy) m70.3488.77 79.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.66.1 43.4%   
Avg P/E ratio x-16.327.7 -58.8%  
P/CF ratio (eoy) x-26.224.6 -106.8%  
Price / Book Value ratio x0.86.4 12.7%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,668129,782 16.7%   
No. of employees `0002.36.8 33.6%   
Total wages/salary Rs m2,0063,765 53.3%   
Avg. sales/employee Rs Th3,587.83,128.4 114.7%   
Avg. wages/employee Rs Th880.0554.0 158.8%   
Avg. net profit/employee Rs Th-583.7689.7 -84.6%   
INCOME DATA
Net Sales Rs m8,18021,258 38.5%  
Other income Rs m610242 252.5%   
Total revenues Rs m8,79021,499 40.9%   
Gross profit Rs m-1,3206,584 -20.1%  
Depreciation Rs m505596 84.8%   
Interest Rs m804 1,953.7%   
Profit before tax Rs m-1,2956,226 -20.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m331,539 2.2%   
Profit after tax Rs m-1,3314,686 -28.4%  
Gross profit margin %-16.131.0 -52.1%  
Effective tax rate %-2.624.7 -10.4%   
Net profit margin %-16.322.0 -73.8%  
BALANCE SHEET DATA
Current assets Rs m23,31812,236 190.6%   
Current liabilities Rs m4,6353,461 133.9%   
Net working cap to sales %228.441.3 553.2%  
Current ratio x5.03.5 142.3%  
Inventory Days Days12260 202.2%  
Debtors Days Days12184 143.8%  
Net fixed assets Rs m8,16311,140 73.3%   
Share capital Rs m141177 79.5%   
"Free" reserves Rs m26,66020,237 131.7%   
Net worth Rs m26,80120,414 131.3%   
Long term debt Rs m310 32.7%   
Total assets Rs m31,89024,486 130.2%  
Interest coverage x-15.21,519.4 -1.0%   
Debt to equity ratio x00 24.9%  
Sales to assets ratio x0.30.9 29.5%   
Return on assets %-3.919.2 -20.5%  
Return on equity %-5.023.0 -21.6%  
Return on capital %-4.530.5 -14.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,35611,667 37.3%   
Fx outflow Rs m01,616 0.0%   
Net fx Rs m4,35610,052 43.3%   
CASH FLOW
From Operations Rs m-1,1232,854 -39.4%  
From Investments Rs m16,487-2,604 -633.1%  
From Financial Activity Rs m-8,811-2 440,565.0%  
Net Cashflow Rs m6,552248 2,640.9%  

Share Holding

Indian Promoters % 50.1 73.8 67.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 1.6 974.2%  
FIIs % 3.0 7.6 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.0 186.5%  
Shareholders   20,176 20,968 96.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   MERCK LTD  STERLING BIOTECH  TORRENT PHARMA  SUVEN LIFE  CIPLA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks ahead of Election Results; Realty Stocks Plummet(Closing)

Indian share markets settled around 2% lower today following a sell-off in the global markets and due to uncertainty over the outcome of state assembly elections tomorrow.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 10, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS